- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05847582
mHealth-supported Skills Training for Alcohol-Related Suicidality Phase 3 (mSTARS)
Pilot RCT to Evaluate Feasibility and Acceptability of mSTARS
Study Overview
Status
Conditions
Detailed Description
Suicide is a high priority public health problem and an increasingly prevalent alcohol-related consequence. One-third of people who die by suicide consume alcohol at hazardous rates in the year preceding death. [Most people in an acute suicide crisis who present for treatment are admitted to acute psychiatric hospitalization. Yet, the 30-day period following discharge from hospitalization is by far the riskiest period for another suicide crisis, (post-discharge rates of suicide are 600 times the global rate). Critically, 50% of suicidal inpatients report alcohol misuse, which further heightens post-discharge risk for suicide.
Acute psychiatric hospitalization focuses on rapid crisis resolution before discharging patients back into their environments with a referral for outpatient care. Outpatient-based cognitive-behavioral skills training in emotion regulation successfully treats concurrent alcohol misuse and suicidal behavior by targeting deficits in emotion regulation associated with both behaviors. Yet, fewer than 50% of psychiatric inpatients follow up with outpatient care once discharged, and those who seek care are often unable to receive it for weeks. Persistently low use of outpatient therapies coupled with alarming post-discharge rates of suicide represents an urgent quality gap. Alternative strategies for inpatient care that extend treatment into the critical post-discharge period are clearly needed to prevent suicide in psychiatric inpatients who misuse alcohol.
The specific aim for this project is to evaluate the feasibility and acceptability of an intervention called mHealth-supported Skills Training for Alcohol-Related Suicidality (mSTARS). Inpatients (N = 35) with suicidal thoughts or behaviors who misuse alcohol will be randomized to one of three study conditions: 1) mSTARS (n = 15), 2) treatment as usual (TAU) plus skills training (n = 10), or 3) TAU alone (n = 10). Primary outcomes include feasibility (e.g., recruitment, retention) and acceptability (e.g., patient satisfaction). Secondary outcomes include suicidal thoughts/behaviors, alcohol use, skills utilization, and rehospitalization.
Participants will complete four study visits, including consent and screening, inpatient treatment, post-treatment assessment, and a 3-month follow-up assessment. After the screening visit, participants will be block-randomized to one of three study conditions listed in item 1.a. above. All participants will receive standard inpatient care. Participants randomized to the mSTARS condition will also receive an intervention that combines inpatient skills training and the mHealth telephone app. Inpatient skills training will be completed while participants are receiving inpatient treatment at BHIP. Skills training includes content designed to improve emotional regulation skills, including motivational enhancement, emotional awareness and acceptance, thinking flexibly, changing emotions, countering cravings, and relapse prevention. Upon discharge from Duke BHIP, patients will download the mHealth app on their personal phones to use in the personal environments for 30 days. The app is designed to encourage participants to apply skills acquired in inpatient skills training to real-life situations. Participants assigned to the TAU plus skills training will receive standard inpatient care plus the inpatient skills training described above. Participants assigned to the TAU condition will receive standard inpatient care only. All participants will be seen for a post-treatment assessment at 30-days and 3-months post-discharge.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jeremy Grove, PhD
- Phone Number: 919-668-0704
- Email: jeremy.grove@duke.edu
Study Contact Backup
- Name: Angela C Kirby, MS
- Email: angela.kirby@duke.edu
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18+
- hospitalized for suicide crisis at Duke BHIP
- an AUDIT-C score indicating hazardous past-month drinking (4 for men; 3 for women) + a 90-day calendar timeline follow-back (TLFB) indicating a minimum of 3 heavy drinking days per week on average (per NIAAA standards)
- owns a smart phone
- fluent in English.
Exclusion Criteria:
- current psychotic or mania symptoms indicated by the MINI Neuropsychiatric Interview 6.0.(MINI)
- receiving ECT at the time of hospitalization, which could inhibit learning
- engaged in weekly outpatient psychotherapy
- discharging to another high level of psychiatric care.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: mSTARS
Participants randomized to the mSTARS condition will receive standard inpatient care while hospitalized at Duke.
They will also receive an intervention that combines inpatient skills training and the mHealth telephone app.
Inpatient emotional regulation skills training will be completed while participants are receiving inpatient treatment at Duke.
Upon discharge from Duke, patients will download the mHealth app on their personal phones to use in their personal environments for 30 days.
The app is designed to encourage participants to apply skills acquired in inpatient skills training to real-life situations.
|
All participants involved in this study will receive standard of care treatment at Duke University Medical Center's Behavioral Health Inpatient Program.
Inpatient skills training will be completed while participants are receiving inpatient treatment at BHIP.
Skills training includes content designed to improve emotional regulation skills.
mSTARS includes inpatient skills training and a mobile health (mHealth) telephone app designed to encourage participants to apply skills acquired in inpatient skills training to real-life situations.
|
|
Active Comparator: Treatment As Usual
Participants randomized to the treatment-as-usual condition will receive standard inpatient care provided at Duke.
|
All participants involved in this study will receive standard of care treatment at Duke University Medical Center's Behavioral Health Inpatient Program.
|
|
Active Comparator: Treatment As Usual + Skills Training
Participants randomized to this condition will receive standard inpatient care and inpatient emotional regulation skills training.
|
All participants involved in this study will receive standard of care treatment at Duke University Medical Center's Behavioral Health Inpatient Program.
Inpatient skills training will be completed while participants are receiving inpatient treatment at BHIP.
Skills training includes content designed to improve emotional regulation skills.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants who rate the intervention a 16 or more on the Client Satisfaction Questionnaire.
Time Frame: 30 days
|
Acceptability of treatment will be measured by an 8-item measure designed to evaluate client satisfaction.
Scores range from 8 to 32, with higher scores indicating higher satisfaction.
|
30 days
|
|
Number of participants who score above threshold (34 or more) on the mHealth Satisfaction Questionnaire
Time Frame: 30 days
|
Acceptability of treatment will be measured by a 14-item measure designed to measure usability of mobile health apps.
Scores range from 14 to 70.
Higher scores indicate higher satisfaction.
|
30 days
|
|
Number of participants who are recruited to participate
Time Frame: 30 days
|
This is an indication of feasibility of being able to recruit enough participants in a timely manner into the protocol.
|
30 days
|
|
Number of participants who complete the post-treatment visit
Time Frame: 30 days
|
Retention will be defined as the number of participants who complete the post-treatment visit that occurs 30 days post-discharge.
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Average score on the Beck Scale for Suicidal Ideation
Time Frame: 30 days
|
Participants will complete the Beck Scale for Suicidal Ideation, a 19-item scale to assess ideation, plans, and/or intent to suicide.
Scores range from 0 to 48, with higher scores indicating higher suicide risk.
|
30 days
|
|
Number of participants who score 40 or less on a measure of perceived efficacy to abstain from alcohol
Time Frame: 30 days
|
Participants will complete the 20-item Alcohol Abstinence Self-Efficacy scale indicating how confident they are in ability to abstain from alcohol in certain situations.
Scores range from 20 to 100, with higher scores indicating higher confidence to abstain from alcohol use.
|
30 days
|
|
Number of participants who report re-hospitalization to an inpatient psychiatry unit.
Time Frame: 30 days
|
Treatment inefficacy will be measured by the number of participants who are re-hospitalized in the 30 day period following their enrollment in the study.
|
30 days
|
|
Average score on the Beck Scale for Suicidal Ideation
Time Frame: 3-month follow-up
|
Participants will complete the Beck Scale for Suicidal Ideation, a 19-item scale to assess ideation, plans, and/or intent to suicide.
Scores range from 0 to 48, with higher scores indicating higher suicide risk.
|
3-month follow-up
|
|
Average number of drinking days
Time Frame: 30 days
|
Patients will self-report the number of drinking days in the period between their post-treatment visit and the 3-month follow-up visit.
|
30 days
|
|
Average number of drinking days
Time Frame: 3-month follow-up
|
Patients will self-report the number of drinking days in the period between their post-treatment visit and the 3-month follow-up visit.
|
3-month follow-up
|
|
Number of participants who report re-hospitalization to an inpatient psychiatry unit.
Time Frame: 3-month follow-up
|
Treatment inefficacy will be measured by the number of participants who are re-hospitalized in the 30 day period following their enrollment in the study.
|
3-month follow-up
|
|
Number of participants who score above 80 on an emotion regulation scale
Time Frame: 30 days
|
Number of participants who score above 80 on an emotion regulation scale
|
30 days
|
|
Number of participants who score above 80 on an emotion regulation scale
Time Frame: 3-month follow-up
|
Number of participants who score above 80 on an emotion regulation scale
|
3-month follow-up
|
|
Number of participants who score 54 or more on a measure of emotion regulation skills use
Time Frame: 30 days
|
The Emotion Regulation Skills Questionnaire is a 27-item measure of the extent to which an individual was able to successfully use emotion regulation skills typically taught in emotion regulation skills training interventions.
Scores range from 0 to 108, and higher scores indicate more successful use of emotional regulation skills.
|
30 days
|
|
Number of participants who score 54 or more on a measure of emotion regulation skills use
Time Frame: 3-month follow-up
|
The Emotion Regulation Skills Questionnaire is a 27-item measure of the extent to which an individual was able to successfully use emotion regulation skills typically taught in emotion regulation skills training interventions.
Scores range from 0 to 108, and higher scores indicate more successful use of emotional regulation skills.
|
3-month follow-up
|
|
Number of participants who score above the clinical range (T score of 70+) on the global severity index of the Symptom Checklist-90
Time Frame: 30 days
|
The Symptom Checklist-90 is A self-report 90-item measure of psychological distress with a T-score range of 30 to 120.
Higher scores indicate higher distress.
|
30 days
|
|
Number of participants who score above the clinical range (T score of 70+) on the global severity index of the Symptom Checklist-90
Time Frame: 3-month follow-up
|
The Symptom Checklist-90 is A self-report 90-item measure of psychological distress with a T-score range of 30 to 120.
Higher scores indicate higher distress.
|
3-month follow-up
|
|
Number of participants who score 40 or less on a measure of perceived efficacy to abstain from alcohol
Time Frame: 3-month follow-up
|
Participants will complete the 20-item Alcohol Abstinence Self-Efficacy scale indicating how confident they are in ability to abstain from alcohol in certain situations.
Scores range from 20 to 100, with higher scores indicating higher confidence to abstain from alcohol use.
|
3-month follow-up
|
|
18. Number of participants who score 40 or less on a measure of perceived efficacy to abstain from alcohol
Time Frame: 30 days
|
Participants will complete the 20-item Alcohol Abstinence Self-Efficacy scale indicating how confident they are in ability to abstain from alcohol in certain situations.
Scores range from 20 to 100, with higher scores indicating higher confidence to abstain from alcohol use
|
30 days
|
|
18. Number of participants who score 40 or less on a measure of perceived efficacy to abstain from alcohol
Time Frame: 3-month follow-up
|
Participants will complete the 20-item Alcohol Abstinence Self-Efficacy scale indicating how confident they are in ability to abstain from alcohol in certain situations.
Scores range from 20 to 100, with higher scores indicating higher confidence to abstain from alcohol use
|
3-month follow-up
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pro00113104_1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Drinking
-
University of North Carolina, Chapel HillNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedDrinking Behavior | Adolescent Behavior | Drinking, Alcohol | Alcohol Drinking, AdolescentUnited States
-
University of Auckland, New ZealandTe Hiringa Hauora/Health Promotion AgencyCompletedDrinking, Alcohol | Consumption, AlcoholNew Zealand
-
Penn State UniversityNot yet recruiting
-
Boston University Charles River CampusActive, not recruiting
-
The Hong Kong Polytechnic UniversityNot yet recruitingHazardous Drinking | Harmful Alcohol Use
-
University of WyomingRecruiting
-
Binghamton UniversityNot yet recruitingUnderage Drinking | Drinking, Teen | Adolescent Alcohol UseUnited States
-
Butler HospitalNational Institute of General Medical Sciences (NIGMS)CompletedDrinking, AlcoholUnited States
-
The University of Hong KongRecruitingmHealth Intervention | AlcoholHong Kong
-
Real Prevention, LLCCompletedUnderage Drinking | Alcohol Use, UnderageUnited States
Clinical Trials on Standard inpatient psychiatric care
-
University Hospital, GenevaFondation Privée des HUG; IF International FoundationRecruitingRecovery | Psychiatric Hospitalization | CoercionSwitzerland
-
Cumhuriyet UniversityNot yet recruitingSchizophrenia | Schizoaffective Disorder | Major Depressive Disorder With Psychotic Features | Bipolar Disorder With Psychotic Features
-
Umeå UniversityVästerbotten County Council, SwedenCompletedMental Ill-health | Care Environment | Light InstallationsSweden
-
Lund UniversityLinkoeping UniversityRecruitingSuicide | Borderline Personality Disorder | Self-harm | Non-suicidal Self-injurySweden
-
University of AarhusUniversity of Rwanda; Mental Health Centre CopenhagenUnknown
-
Assistance Publique Hopitaux De MarseilleCompletedSchizophrenia | Bipolar I DisorderFrance
-
Kuopio University HospitalUniversity of Eastern FinlandTerminatedPsychiatric DiseasesFinland
-
The University of Texas Health Science Center,...CompletedChronic IllnessesUnited States
-
Akdeniz UniversityCompletedPostoperative Pain | Preoperative Anxiety | Living Kidney DonationTurkey (Türkiye)
-
Jennifer HughesNational Institute of Mental Health (NIMH); Ohio State UniversityRecruitingSuicidal Ideation | Suicide, Attempted | Suicide | Suicide Threat | Suicide and Self-harmUnited States